Articles by Walter Armstrong - Pharmaceutical Executive


Articles by Walter Armstrong

The Big Reset

Jan 20, 2010

Pharm Exec's 2010 crystal ball reveals an industry in upheaval on many fronts. Is going back to the future the answer?

Fight or Flight?

Dec 1, 2009

As the old orthodoxy shatters, pharma must stand firm or leave the field.

The Book on Daniel

Oct 1, 2009

Novartis CEO Daniel Vasella has built the Swiss firm into the fastest growing pharma in the world, and in the process gained a reputation as an outspoken visionary. But is he really as good as all that?

What's the Deal at Solvay?

Aug 1, 2009

The Belgian drugmaker is pursuing a sale, inking deals, issuing debt, and launching a power drug for Parkinson's—all at once.

Betting the Pharma

Aug 1, 2009

With the biotech industry reeling from the recession, big drugmakers hold all the cards when it comes to making deals, but picking a winner is still a gamble. Here are 10 to place stakes on.

French Revolution

Jul 1, 2009

Chris Viehbacher's first fast and furious six months at the top of Sanofi-Aventis have heads spinning...and rolling.

ASCO Roundup: Winners, Losers, and Also Rans

Jun 3, 2009

Due to pharma's voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week?s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida.

Attack of the Monster Merger

Mar 1, 2009

Just when you thought it was safe to go back into M&A, the mega merger returns. What's right about Pfizer-Wyeth, and what's scary.

Brand of the Year: Crestor

Feb 1, 2009

For aiming to be a game-changer in cardiovascular disease, we recognize comeback kid Crestor as the year's No. 1. Plus three fine finalists.


Click here